ARTELO BIOSCIENCES, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
ARTELO BIOSCIENCES, INC. (ARTL) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$1.73 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-12
- ARTELO BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$2.76M, a 222.89% decline year-over-year.
- ARTELO BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $1.03M, a 28.62% increase year-over-year.
- ARTELO BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$832.00K, a 177.18% decline year-over-year.
- ARTELO BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$906.00K.
- ARTELO BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was -$10.00K.
- ARTELO BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2021 was -$3.00K, a 102.34% decline from fiscal 2020.
- ARTELO BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2020 was $128.00K.
- ARTELO BIOSCIENCES, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2019 was -$180.41K, a 136.03% decline from fiscal 2018.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 4 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$1.73M 10-Q · filed 2026-08-12 | -$2.56M derived: sum of 3 quarters · filed 2026-08-12 | -$3.47M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $1.03M 10-Q · filed 2026-05-14 | $197.00K derived: sum of 2 quarters · filed 2026-05-14 | -$709.00K derived: sum of 3 quarters · filed 2026-05-14 | $1.54M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | -$832.00K derived: 8-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$1.74M derived: sum of 2 quarters · filed 2026-03-17 | $508.00K derived: sum of 3 quarters · filed 2026-08-12 | $1.31M 8-K · filed 2026-03-17 | ||||
| 2025-09-30 | -$906.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.34M derived: sum of 2 quarters · filed 2026-08-12 | $2.14M 10-Q · filed 2025-11-12 | $3.22M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | $2.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $3.05M 10-Q · filed 2026-08-12 | $4.12M derived: sum of 3 quarters · filed 2026-08-12 | $3.86M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | $800.00K 10-Q · filed 2026-05-14 | $1.88M derived: sum of 2 quarters · filed 2026-05-14 | $1.62M derived: sum of 3 quarters · filed 2026-05-14 | $1.87M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $1.08M derived: 8-K 12 month − 10-Q 9 month · filed 2026-03-17 | $817.00K derived: sum of 2 quarters · filed 2026-03-17 | $1.07M derived: sum of 3 quarters · filed 2026-03-17 | $449.00K 8-K · filed 2026-03-17 | ||||
| 2024-09-30 | -$261.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$5.00K derived: sum of 2 quarters · filed 2025-11-12 | -$629.00K 10-Q · filed 2025-11-12 | -$261.00K derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $256.00K derived: 10-Q 6 month − 8-K 3 month · filed 2025-08-13 | -$368.00K 10-Q · filed 2025-08-13 | $0.00 derived: sum of 3 quarters · filed 2025-08-13 | $330.00K derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | -$624.00K 8-K · filed 2025-07-11 | -$256.00K derived: sum of 2 quarters · filed 2025-07-11 | $74.00K derived: sum of 3 quarters · filed 2025-07-11 | -$114.00K derived: sum of 4 quarters · filed 2025-07-11 | ||||
| 2023-12-31 | $368.00K derived: 8-K 12 month − 10-Q 9 month · filed 2025-07-11 | $698.00K derived: sum of 2 quarters · filed 2025-07-11 | $510.00K derived: sum of 3 quarters · filed 2025-07-11 | $296.00K 8-K · filed 2025-07-11 | ||||
| 2023-09-30 | $330.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $142.00K derived: sum of 2 quarters · filed 2024-11-12 | -$72.00K 10-Q · filed 2024-11-12 | $480.00K derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$188.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$402.00K 10-Q · filed 2024-08-13 | $150.00K derived: sum of 3 quarters · filed 2024-08-13 | $131.00K derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | -$214.00K 10-Q · filed 2024-05-13 | $338.00K derived: sum of 2 quarters · filed 2024-05-13 | $319.00K derived: sum of 3 quarters · filed 2024-05-13 | -$64.00K derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | $552.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $533.00K derived: sum of 2 quarters · filed 2024-03-25 | $150.00K derived: sum of 3 quarters · filed 2024-03-25 | -$10.00K 10-K · filed 2024-03-25 | ||||
| 2022-09-30 | -$19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$402.00K derived: sum of 2 quarters · filed 2023-11-13 | -$562.00K 10-Q · filed 2023-11-13 | |||||
| 2022-06-30 | -$383.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$543.00K 10-Q · filed 2023-08-10 | ||||||
| 2022-03-31 | -$160.00K 10-Q · filed 2023-05-11 | |||||||
| 2021-12-31 | $507.00K 10-K · filed 2023-03-31 | |||||||
| 2021-11-30 | $132.00K 10-Q · filed 2022-01-12 | |||||||
| 2021-09-30 | $271.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$342.00K 10-Q · filed 2022-11-08 | ||||||
| 2021-08-31 | $82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$3.00K 10-K · filed 2023-03-31 | ||||||
| 2021-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$613.00K 10-Q · filed 2022-08-09 | ||||||
| 2021-05-31 | -$164.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-12 | -$85.00K 10-Q · filed 2021-07-12 | ||||||
| 2021-03-31 | -$634.00K 10-Q · filed 2022-05-12 | |||||||
| 2021-02-28 | $111.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-13 | $79.42K 10-Q · filed 2021-04-13 | $295.65K derived: sum of 3 quarters · filed 2022-03-21 | $119.37K derived: sum of 4 quarters · filed 2022-03-21 | ||||
| 2020-12-31 | $444.00K 10-KT · filed 2022-03-21 | |||||||
| 2020-11-30 | -$32.00K 10-Q · filed 2022-01-12 | -$18.04K 10-Q · filed 2021-01-14 | $184.23K derived: sum of 2 quarters · filed 2022-03-21 | $7.95K derived: sum of 3 quarters · filed 2022-03-21 | -$134.67K derived: sum of 4 quarters · filed 2022-03-21 | |||
| 2020-08-31 | $216.23K derived: 10-KT 12 month − 10-Q 9 month · filed 2022-03-21 | $39.95K derived: sum of 2 quarters · filed 2022-03-21 | -$102.67K derived: sum of 3 quarters · filed 2022-03-21 | $128.00K 10-KT · filed 2022-03-21 | $127.98K 10-K · filed 2020-11-04 | |||
| 2020-05-31 | -$176.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-12 | -$318.90K derived: sum of 2 quarters · filed 2021-07-12 | -$88.23K 10-Q · filed 2021-07-12 | -$360.11K derived: sum of 4 quarters · filed 2021-07-12 | ||||
| 2020-02-29 | -$142.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-13 | $88.05K 10-Q · filed 2021-04-13 | -$183.83K derived: sum of 3 quarters · filed 2021-04-13 | -$149.09K derived: sum of 4 quarters · filed 2021-04-13 | ||||
| 2019-11-30 | $230.67K 10-Q · filed 2021-01-14 | -$41.21K derived: sum of 2 quarters · filed 2021-01-14 | -$6.47K derived: sum of 3 quarters · filed 2021-01-14 | -$55.17K derived: sum of 4 quarters · filed 2021-01-14 | ||||
| 2019-08-31 | -$271.88K derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-04 | -$237.14K derived: sum of 2 quarters · filed 2020-11-04 | -$285.84K derived: sum of 3 quarters · filed 2020-11-04 | -$180.41K 10-K · filed 2020-11-04 | ||||
| 2019-05-31 | $34.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-07-13 | -$13.96K derived: sum of 2 quarters · filed 2020-07-13 | $91.47K 10-Q · filed 2020-07-13 | $131.12K derived: sum of 4 quarters · filed 2020-07-13 | ||||
| 2019-02-28 | -$48.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-13 | $56.73K 10-Q · filed 2020-04-13 | $96.37K derived: sum of 3 quarters · filed 2020-04-13 | $261.68K derived: sum of 4 quarters · filed 2020-04-13 | ||||
| 2018-11-30 | $105.43K 10-Q · filed 2020-01-14 | $145.07K derived: sum of 2 quarters · filed 2020-01-14 | $310.38K derived: sum of 3 quarters · filed 2020-01-14 | $500.73K derived: sum of 4 quarters · filed 2020-01-14 | ||||
| 2018-08-31 | $39.64K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-18 | $204.95K derived: sum of 2 quarters · filed 2019-12-18 | $395.30K derived: sum of 3 quarters · filed 2019-12-18 | $500.70K 10-K/A · filed 2019-12-18 | ||||
| 2018-05-31 | $165.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-15 | $355.65K derived: sum of 2 quarters · filed 2019-07-15 | $461.05K 10-Q · filed 2019-07-15 | $418.31K derived: sum of 4 quarters · filed 2019-07-15 | ||||
| 2018-02-28 | $190.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-15 | $295.75K 10-Q · filed 2019-04-15 | $125.64K 10-Q · filed 2018-04-16 | $253.01K derived: sum of 3 quarters · filed 2019-04-15 | $321.91K derived: sum of 4 quarters · filed 2019-04-15 | |||
| 2017-11-30 | $105.40K 10-Q · filed 2019-01-14 | $62.66K derived: sum of 2 quarters · filed 2019-01-14 | $131.56K derived: sum of 3 quarters · filed 2019-01-14 | $123.92K derived: sum of 4 quarters · filed 2019-01-14 | ||||
| 2017-08-31 | -$42.74K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-29 | $26.16K derived: sum of 2 quarters · filed 2018-11-29 | $18.52K derived: sum of 3 quarters · filed 2018-11-29 | $15.64K 10-K · filed 2018-11-29 | ||||
| 2017-05-31 | $68.90K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2018-07-13 | $61.26K derived: sum of 2 quarters · filed 2018-07-13 | $58.37K 10-Q · filed 2018-07-13 | $62.70K derived: sum of 4 quarters · filed 2018-07-13 | ||||
| 2017-02-28 | -$7.64K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-05-14 | -$10.53K 10-Q/A · filed 2018-05-14 | -$6.20K derived: sum of 3 quarters · filed 2018-05-14 | -$5.00K derived: sum of 4 quarters · filed 2018-05-14 | ||||
| 2016-11-30 | -$2.89K 10-Q/A · filed 2018-03-21 | $1.44K derived: sum of 2 quarters · filed 2018-03-21 | $2.64K derived: sum of 3 quarters · filed 2018-03-21 | $7.35K derived: sum of 4 quarters · filed 2018-03-21 | ||||
| 2016-08-31 | $4.33K derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-29 | $5.53K derived: sum of 2 quarters · filed 2017-11-29 | $10.24K derived: sum of 3 quarters · filed 2017-11-29 | $11.20K 10-K · filed 2017-11-29 | ||||
| 2016-05-31 | $1.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-07-21 | $5.91K derived: sum of 2 quarters · filed 2017-07-21 | $6.87K 10-Q · filed 2017-07-21 | |||||
| 2016-02-29 | $4.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-04-14 | $5.67K 10-Q · filed 2017-04-14 | ||||||
| 2015-11-30 | $961.00 10-Q · filed 2017-01-10 | |||||||
| 2015-08-31 | $1.74K 10-K · filed 2016-11-29 | |||||||
| 2015-02-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-04-01 | $1.50K 10-Q · filed 2016-04-01 | ||||||
| 2014-11-30 | $1.50K 10-Q · filed 2016-01-14 | |||||||
| 2014-02-28 | $6.50K 10-Q · filed 2015-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |